Sanada Hajime, Yamaguchi Kaori, Miyake Taito
Division of Nephrology and Rheumatology, Kouseiren Takaoka Hospital, Takaoka, JPN.
Cureus. 2021 Jun 12;13(6):e15608. doi: 10.7759/cureus.15608.
Dialysis disequilibrium syndrome (DDS) is a neurological complication that has been known to occur after hemodialysis (HD). In recent years, the prevalence of DDS has been low as the symptoms are widely recognized; hence, preventive therapies, such as the slow and gentle procedure for HD, are often administered before starting dialysis. However, once DDS occurs, it may cause seizures, coma, and even death in severe cases. Since there has been no established treatment, recognizing risk factors and preventing the syndrome is important. A 76-year-old man was admitted to our hospital due to exacerbation of chronic heart failure. He also had a history of chronic kidney disease and had consulted with his home doctor about the preparation for HD a month before admission. After treatment with diuretics, the symptoms ameliorated, but he experienced presyncope and malaise. Laboratory tests revealed acute anemia and a decrease in renal function. Upper gastrointestinal endoscopy revealed active bleeding from a gastric ulcer, which was successfully stopped. However, his consciousness deteriorated because of uremia; hence, HD was initiated. We used a cellulose triacetate membrane with a surface area of 1.3 m and maintained a dialysate flow rate of 500 ml/min with a blood flow rate of 120 ml/min. Four hours after starting HD, he suddenly developed generalized tonic convulsions. The dialysis was immediately stopped, and the patient was transferred to an intensive care unit. A computed tomography scan of the head showed mild edematous change of the brain, and laboratory tests also revealed a rapid decrease of urea nitrogen. We rationalized that he might have developed DDS. After injection of levetiracetam for the treatment of seizures, we initiated continuous hemodiafiltration as renal replacement therapy. Fortunately, his consciousness gradually improved, and he was completely alert on day 18 after admission. With reference to our current report, DDS can occur even following acute kidney injury, as the progression rate of the injury and accumulation of blood urea may not correlate with the risk of the syndrome.
透析失衡综合征(DDS)是一种已知在血液透析(HD)后发生的神经系统并发症。近年来,由于症状得到广泛认识,DDS的患病率较低;因此,在开始透析前常采用诸如缓慢温和的HD程序等预防性治疗方法。然而,一旦发生DDS,在严重情况下可能会导致癫痫发作、昏迷甚至死亡。由于尚无既定的治疗方法,识别风险因素并预防该综合征很重要。一名76岁男性因慢性心力衰竭加重入住我院。他还有慢性肾脏病病史,入院前一个月已就HD准备事宜咨询过家庭医生。经利尿剂治疗后,症状有所改善,但他出现了前驱晕厥和不适。实验室检查显示急性贫血和肾功能下降。上消化道内镜检查发现胃溃疡活动性出血,出血成功止住。然而,由于尿毒症他的意识恶化;因此,开始进行HD。我们使用了表面积为1.3平方米的三醋酸纤维素膜,维持透析液流速为500毫升/分钟,血流速度为120毫升/分钟。开始HD后4小时,他突然出现全身性强直惊厥。透析立即停止,患者被转入重症监护病房。头部计算机断层扫描显示脑部有轻度水肿改变,实验室检查还显示尿素氮迅速下降。我们推断他可能发生了DDS。在注射左乙拉西坦治疗癫痫发作后,我们开始进行连续性血液透析滤过作为肾脏替代治疗。幸运的是,他的意识逐渐改善,入院后第18天完全清醒。参照我们目前的报告,即使在急性肾损伤后也可能发生DDS,因为损伤的进展速度和血尿素的积累可能与该综合征的风险无关。